Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,223,265 papers from all fields of science
Search
Sign In
Create Free Account
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Known as:
HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI)
, HBV NRTI
, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Hepatitis B
Nucleoside Analogs
Nucleoside Reverse Transcriptase Inhibitors [MoA]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Correction for Sohl et al., Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ
C. Sohl
,
M. Szymanski
,
A. C. Mislak
,
Christie K. Shumate
,
Sheida Amiralaei
,
R. Schinazi
Proceedings of the National Academy of Sciences
2016
Corpus ID: 205278496
BIOCHEMISTRY Correction for “Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA…
Expand
2015
2015
Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ
C. Sohl
,
M. Szymanski
,
+5 authors
Y. Yin
Proceedings of the National Academy of Sciences
2015
Corpus ID: 6888202
Significance Nucleoside analog reverse transcriptase inhibitors (NRTIs) are the cornerstones of treatment for fighting HIV…
Expand
2012
2012
NRTI Backbone in HIV Treatment
R. Tressler
,
C. Godfrey
Drugs
2012
Corpus ID: 25988397
Nucleoside reverse transcriptase inhibitors (NRTIs) remain a critical component of therapy for HIV-infected patients. The drugs…
Expand
2012
2012
Dolutegravir treatment response by baseline viral load and NRTI backbone in treatment‐naïve HIV‐infected individuals
J. Eron
,
J. Rockstroh
,
+6 authors
R. Cuffe
2012
Corpus ID: 73773837
In two 48‐week studies in naïve subjects, dolutegravir with NRTI of choice has shown non‐inferiority to raltegravir and, with ABC…
Expand
2008
2008
Short communication: the number of HIV major NRTI mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility…
L. Ross
,
N. Parkin
,
R. Lanier
AIDS Research and Human Retroviruses
2008
Corpus ID: 5503561
While it is known that selection for specific HIV-1 drug resistance-associated mutations (DRM) occurs following ART failure, the…
Expand
2008
2008
Effects of NRTI Backbone on Efficacy of First-line Boosted Pi Based Haart - Meta-analysis of 12 Clinical Trials in 4896 Patients
A. Hill
2008
Corpus ID: 74825307
2007
2007
Intracellular Nucleoside Triphosphate Concentrations in HIV-Infected Patients on Dual Nucleoside Reverse Transcriptase Inhibitor Therapy
Jeff D. Moore
,
E. Acosta
,
+6 authors
J. Sommadossi
Antiviral Therapy
2007
Corpus ID: 12176902
Background Intracellular nucleoside reverse transcriptase inhibitor triphosphate (NRTI-TP) concentrations are crucial in…
Expand
2007
2007
Observational Study on HIV-Infected Subjects Failing HAART Receiving Tenofovir Plus Didanosine as NRTI Backbone
M. Bongiovanni
,
N. Gianotti
,
+16 authors
A. d’Arminio Monforte
Infection
2007
Corpus ID: 24445130
We evaluated the efficacy of tenofovir (TDF) – and didanosine (ddI)-containing backbones in HIV-infected experienced subjects. We…
Expand
Review
2006
Review
2006
Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects.
M. Bongiovanni
,
F. Tordato
Current Medicinal Chemistry
2006
Corpus ID: 34136540
Nucleoside reverse transcriptase inhibitors (NRTI) are essential components of highly active antiretroviral treatment (HAART…
Expand
Review
2003
Review
2003
Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone.
G. Moyle
The AIDS reader
2003
Corpus ID: 26167838
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE